Raj Kannan, CEO of Chiasma, discusses the company’s recently approved therapy for acromegaly, the company’s drug delivery technology, and the value of having oral alternatives to injectable therapies.
Raj Kannan, CEO of Chiasma, discusses the company’s recently approved therapy for acromegaly, the company’s drug delivery technology, and the value of having oral alternatives to injectable therapies.